Krka, d. d.

WSE:KRK Stock Report

Market Cap: zł33.7b

Krka d. d Valuation

Is KRK undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of KRK when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: KRK (PLN1120) is trading below our estimate of future cash flow value (PLN1302.01)

Significantly Below Future Cash Flow Value: KRK is trading below future cash flow value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for KRK?

Key metric: As KRK is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for KRK. This is calculated by dividing KRK's market cap by their current earnings.
What is KRK's PE Ratio?
PE Ratio18.7x
Earnings€417.65m
Market Cap€7.83b

Price to Earnings Ratio vs Peers

How does KRK's PE Ratio compare to its peers?

The above table shows the PE ratio for KRK vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average17.2x
CLN Celon Pharma
10.3x-139.92%zł1.1b
4523 Eisai
31.6x10.50%JP¥1.4t
4151 Kyowa Kirin
16.3x4.25%JP¥1.4t
HTSU.Y Hisamitsu Pharmaceutical
10.6xn/aUS$8.2b
KRK Krka d. d
18.7x3.94%zł7.8b

Price-To-Earnings vs Peers: KRK is expensive based on its Price-To-Earnings Ratio (18.7x) compared to the peer average (17.5x).

Historical Price to Earnings Ratio

Historical Price to Earnings Ratio compares a stock's price to its earnings over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Earnings Ratio vs Industry

How does KRK's PE Ratio compare vs other companies in the European Pharmaceuticals Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
KRK 18.7xIndustry Avg. 21.6xNo. of Companies10PE01632486480+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: KRK is good value based on its Price-To-Earnings Ratio (18.7x) compared to the European Pharmaceuticals industry average (21.6x).

Price to Earnings Ratio vs Fair Ratio

What is KRK's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

KRK PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio18.7x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate KRK's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst KRK forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentzł1,120.00
zł1,056.57
-5.66%
24.97%zł1,288.19zł494.63n/a6
Aug ’27zł1,130.00
zł1,047.57
-7.29%
25.40%zł1,293.01zł496.48n/a6
Jul ’27zł1,096.00
zł965.11
-11.94%
28.14%zł1,269.72zł487.54n/a6
Jun ’27zł1,082.00
zł894.00
-17.38%
26.44%zł1,230.27zł487.87n/a6
May ’27zł1,022.00
zł873.00
-14.58%
23.40%zł1,078.89zł491.57n/a6
Apr ’27zł980.00
zł873.00
-10.92%
23.40%zł1,078.89zł491.57n/a6
Mar ’27zł1,025.00
zł839.63
-18.09%
22.05%zł1,057.61zł484.56n/a6
Feb ’27zł964.00
zł839.63
-12.90%
22.05%zł1,057.61zł484.56n/a6
Jan ’27zł860.00
zł814.64
-5.27%
20.19%zł993.12zł486.00n/a6
Dec ’26zł880.00
zł814.64
-7.43%
20.19%zł993.12zł486.00n/a6
Nov ’26zł890.00
zł813.09
-8.64%
20.39%zł1,001.62zł490.15n/a6
Oct ’26zł918.00
zł789.38
-14.01%
19.56%zł999.58zł489.16n/a6
Sep ’26zł842.00
zł789.38
-6.25%
19.56%zł999.58zł489.16n/a6
Aug ’26zł850.00
zł780.97
-8.12%
19.87%zł998.79zł488.77zł1,130.006
Jul ’26zł816.00
zł743.72
-8.86%
16.34%zł879.91zł491.21zł1,096.006
Jun ’26zł784.00
zł734.29
-6.34%
16.70%zł878.85zł490.62zł1,082.006
May ’26zł746.00
zł731.21
-1.98%
17.10%zł881.13zł491.89zł1,022.006
Apr ’26zł720.00
zł716.85
-0.44%
17.10%zł863.83zł482.23zł980.006
Mar ’26zł700.00
zł631.13
-9.84%
15.33%zł754.25zł481.88zł1,025.006
Feb ’26zł680.00
zł613.85
-9.73%
13.11%zł746.99zł484.78zł964.006
Jan ’26zł586.00
zł610.44
+4.17%
15.51%zł759.35zł492.81zł860.006
Dec ’25zł598.00
zł568.97
-4.86%
12.47%zł662.58zł491.59zł880.006
Nov ’25zł586.00
zł568.97
-2.91%
12.47%zł662.58zł491.59zł890.006
Oct ’25zł578.00
zł568.97
-1.56%
12.47%zł662.58zł491.59zł918.006
Sep ’25zł584.00
zł567.44
-2.84%
11.35%zł646.37zł495.55zł842.006
Aug ’25zł604.00
zł564.09
-6.61%
11.84%zł645.00zł481.60zł850.006
zł1.06k
Fair Value
5.2% overvalued intrinsic discount
6
Number of Analysts

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/17 07:09
End of Day Share Price 2026/08/14 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Krka, d. d. is covered by 9 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Simon MatherBarclays
Stephane SumarBNP Paribas
Jamie ClarkBofA Global Research